SafeBoosC-II

Official title: A phase II randomized clinical trial on cerebral near-infrared spectroscopy plus a treatment guideline versus treatment as usual for extremely preterm infants during the first three days of life

Trial start year: 2012

Trial website

View website below
View website

Trial registration

NCT01590316
View registration
Design paper

Design paper

2013

A phase II randomized clinical trial on cerebral near-infrared spectroscopy plus a treatment guideline versus treatment as usual for extremely preterm infants during the first three days of life (SafeBoosC): study protocol for a randomized controlled trial.
Download full paper
Result paper

Result paper

2015

Cerebral near infrared spectroscopy oximetry in extremely preterm infants: phase II randomised clinical trial.
Download full paper